$2.35T
Total marketcap
$80.14B
Total volume
BTC 50.52%     ETH 14.75%
Dominance

Integrated Pharmaceuticals INTP Stock

0 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
1.79K USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
2K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Integrated Pharmaceuticals Price Chart

Integrated Pharmaceuticals INTP Financial and Trading Overview

Integrated Pharmaceuticals stock price 0.0000 USD
Previous Close 1.0E-6 USD
Open 1.0E-6 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 1.0E-6 - 1.0E-6 USD
52 Week Range 1.0E-6 - 0.0001 USD
Volume 2K USD
Avg. Volume 0 USD
Market Cap 1.79K USD
Beta (5Y Monthly) 46.630985
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (3.06%)
Ex-Dividend Date N/A
1y Target Est N/A

INTP Valuation Measures

Enterprise Value -180805 USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.066185184
Price/Book (mrq) 8.333333E-5
Enterprise Value/Revenue -6.697
Enterprise Value/EBITDA 0.304

Trading Information

Integrated Pharmaceuticals Stock Price History

Beta (5Y Monthly) 46.630985
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 0.0001 USD
52 Week Low 1.0E-6 USD
50-Day Moving Average 0.0001 USD
200-Day Moving Average 0.0001 USD

INTP Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 0
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:4

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2007
Most Recent Quarter (mrq) June 30, 2008
Next Fiscal Year End December 31, 2008

Profitability

Profit Margin 0%
Operating Margin (ttm) -4229.014%
Gross Margin 82.50%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -57.38%
Return on Equity (ttm) -190.73%

Income Statement

Revenue (ttm) 27K USD
Revenue Per Share (ttm) 0.001 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 23K USD
EBITDA -594128 USD
Net Income Avi to Common (ttm) -1702112 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 180.85K USD
Total Cash Per Share (mrq) 0.004 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1
Book Value Per Share (mrq) 0.012

Cash Flow Statement

Operating Cash Flow (ttm) -908644 USD
Levered Free Cash Flow (ttm) 76.65K USD

Profile of Integrated Pharmaceuticals

Country United States
State MA
City Fitchburg
Address 310 Authority Drive
ZIP 01420
Phone 978-696-0020
Website N/A
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 4

Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.

Q&A For Integrated Pharmaceuticals Stock

What is a current INTP stock price?

Integrated Pharmaceuticals INTP stock price today per share is 0.0000 USD.

How to purchase Integrated Pharmaceuticals stock?

You can buy INTP shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Integrated Pharmaceuticals?

The stock symbol or ticker of Integrated Pharmaceuticals is INTP.

Which industry does the Integrated Pharmaceuticals company belong to?

The Integrated Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.

How many shares does Integrated Pharmaceuticals have in circulation?

The max supply of Integrated Pharmaceuticals shares is 0.

What is Integrated Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Integrated Pharmaceuticals PE Ratio is now.

What was Integrated Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Integrated Pharmaceuticals EPS is 0 USD over the trailing 12 months.

Which sector does the Integrated Pharmaceuticals company belong to?

The Integrated Pharmaceuticals sector is Healthcare.